Further growth for regulatory affairs team at Boyds with appointment of Harriet Edwards
We are pleased to announce the appointment of experienced regulatory professional, Harriet Edwards, in response to a sustained rise in demand for specialist regulatory services and expertise. With more than nine years’ experience in regulatory affairs across generic pharmaceuticals, early stage clinical CROs and biotech companies, Harriet joins Boyds as Associate Director of Regulatory Affairs. […]
